ARS Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
4.00
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
4
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-09-30
|
-0.15
|
-0.20
|
-0.05
|
-33.33%
|
|
2024-06-30
|
-0.12
|
-0.13
|
-0.01
|
-8.33%
|
|
2024-03-31
|
-0.11
|
-0.11
|
0.00
|
0.00%
|
|
2023-12-31
|
-0.14
|
-0.07
|
0.07
|
50.00%
|
|
2023-09-30
|
-0.18
|
-0.16
|
0.02
|
11.11%
|
|
2023-06-30
|
-0.17
|
-0.18
|
-0.01
|
-5.88%
|
|
2023-03-31
|
-0.17
|
-0.16
|
0.01
|
5.88%
|
|
2022-12-31
|
-0.13
|
0.77
|
0.90
|
692.31%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-09-30
|
-0.44
|
|
2023-12-31
|
-0.57
|
|
2022-12-31
|
-0.98
|
|
2021-12-31
|
-2.56
|
|
2020-12-31
|
-2.07
|